+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compounding an extended-stability admixture of Paclitaxel for long-term infusion

Compounding an extended-stability admixture of Paclitaxel for long-term infusion

International Journal of Pharmaceutical Compounding 1(1): 49-53

Conventional paclitaxel admixtures are not physically stable; precipitation occurs which interferes with multiday continuous infusion, a delivery mode being evaluated in clinical trials. The purpose of this article is to describe an extemporaneous compounding approach that extends the stability of paclitaxel admixtures and to provide documentation of the pharmaceutical acceptability of these admixtures. Paclitaxel admixtures have been found to be chemically stable until they precipitate. Microcrystalline precipitation may begin after 3 days. The physical stability of paclitaxel admixtures was found to increase when ethanol concentrations in the final admixtures were raised from the usual 8.3% to 20% to 25% or more. The extended-stability admixtures were compounded at a paclitaxel concentration of 1 mg/mL by adding additional sterile dehydrated alcohol injection, USP, along with the paclitaxel concentrate for injection to 5% dextrose injection, USP,to bring the ethanol concentration to 20% and to 25% in the final admixtures. The chemical and physical stability of the admixtures was evaluated at 4 deg, 22 deg, and 32 deg C over periods up to 31 days. Using a stability-indicating high performance liquid chromatographic assay, no loss of paclitaxel due to decomposition was found in any sample. Precipitation occurred in a few samples within the observation periods. Substantial losses (up to 70%) occurred in the few samples that precipitated. The addition of sterile dehydrated alcohol injection, USP, to paclitaxel admixtures in 5% dextrose injection, increasing the final ethanol concentration to about 25%, results in paclitaxel admixtures that are physically and chemically stable for at least 7 days, and possibly up to 14 days, at 4 deg, 22 deg, and 32 deg C.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 052269307

Download citation: RISBibTeXText

PMID: 23995889

Related references

Stability and sterility of parenteral nutrition admixture for patients home care manufactured by the automated compounding BAXA® EM 2400. Annales Pharmaceutiques Francaises 71(6): 401-409, 2014

Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer. European Journal of Cancer 50(15): 2592-2601, 2014

Long-term weekly paclitaxel over 1 hour infusion with limited premedication A phase II trial report. European Journal of Cancer 35(SUPPL 4): S326, Sept, 1999

Long-term weekly Paclitaxel over 1 hour infusion with de-escalated premedication A Phase II trial report. Breast Cancer Research & Treatment 57(1): 123, 1999

Long term stability of a total nutrient admixture tna for total parenteral nutrition tpn. Journal of the American College of Nutrition 8(5): 432, 1989

Long-term, weekly one-hour infusion of paclitaxel in patients with metastatic breast cancer: a phase II monoinstitutional study. Tumori 90(3): 285-288, 2004

Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: Results of a phase II trial. Cancer 92(3): 642-649, August 1, 2001

Paclitaxel, carboplatin, and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies: preliminary results of phase II trial. Seminars in Oncology 24(6 Suppl 19): S19-38-S19-42, 1998

The stability of sulphadiazine sodium as used in admixture with intravenous infusion fluids. Journal of Clinical Pharmacy and Therapeutics 1(1): 39-48, 1976

Stability of flomoxef in aqueous solution and in intravenous admixture of 5 percent glucose infusion. Yakugaku Zasshi 108(8): 777-787, 1988

Oil-Infused Superhydrophobic Silicone Material for Low Ice Adhesion with Long-Term Infusion Stability. Acs Applied Materials and Interfaces 8(46): 32050-32059, 2016

Assessment of the long-term stability of retort pouch foods to support extended duration spaceflight. Journal of Food Science 77(1): S29-S39, 2012

Extended stability formulations for paclitaxel. Official Gazette of the United States Patent & Trademark Office Patents 1203(4): 3009, Oct 28, 1997

Long-term results of a phase II trial of induction paclitaxel-carboplatin followed by concurrent radiation therapy and weekly paclitaxel and consolidation paclitaxel-carboplatin in stage III non-small cell lung cancer. Journal of Thoracic Oncology 6(1): 79-85, 2011

Hygienic relations and stability of drugs in peridural long-term infusion with implanted or external pumps. Der Anaesthesist 34(5): 247-251, 1985